Trial Profile
Efficacy and tolerability of nebulised aqueous budesonide suspension in adolescent and adult patients with active eosinophilic esophagitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Eosinophilic oesophagitis
- Focus Biomarker; Therapeutic Use
- 24 Feb 2011 New trial record